The objective of this study was to shed light on whether there are other antigens that could
supersede
or
synergize
with RH5 in their ability to elicit growth-inhibitory antibodies against blood-stage
This will inform the approach taken to improve on the present RH5 vaccine and/or develop next-generation vaccine formulations targeting multiple antigens to achieve even higher levels of growth inhibitory antibodies.